Johnson Afari

Statistics

Publications

Citations

139

H-Index

Active since

2013

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

Johnson Afari is an author at GlaxoSmithKline (United Kingdom) specializing in high-throughput cell screening, tuberculosis drug development, and synthetic medicinal chemistry.

Publications per year

2013–2013

Publications

Tetrahydropyrazolo[1,5-a]Pyrimidine-3-Carboxamide and N-Benzyl-6′,7′-Dihydrospiro[Piperidine-4,4′-Thieno[3,2-c]Pyran] Analogues with Bactericidal Efficacy against Mycobacterium tuberculosis Targeting MmpL3

Modesto J. Remuiñán, Esther Pérez‐Herrán, Joaquín Rullás et al. · PLoS ONE · 2013 · 139 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

1–1 of 1